GGrantIndex
Sort

17,288 grants matching multiple sclerosis

Autoimmune responses associated with SARS-CoV-2 infection

$222,889
Sarah E. Wheeler · University Of Pittsburgh At Pittsburgh · R21 · FY2022 · AI

Human Keratin (K14)-MBP/MBP-TCR Transgenic Animal Model

$222,800
Kouichi Ito · Univ Of Med/Dent Nj-R W Johnson Med Sch · R21 · FY2009 · AI

STAT3 and astrogliogenesis in HIV-1 associated dementia

$222,750
Hui Peng · University Of Nebraska Medical Center · R21 · FY2009 · NS

Molecular Mechanisms of Multiple Sclerosis Disease Severity In African Americans

$222,750
Chander Raman · University Of Alabama At Birmingham · R21 · FY2021 · MD

Esomeprazole counteracts chlorine toxicity in pregnant animals

$222,750
Tamas Jilling · University Of Alabama At Birmingham · R21 · FY2021 · ES

HIV neuroinflammation alters brain microstructure and viscoelastic properties

$222,719
Giovanni Schifitto · University Of Rochester · R21 · FY2019 · NS

The role of ABCC6 in diabetic vascular calcification

$222,701
Viola Pomozi · University Of Hawaii At Manoa · P20 · FY2019 · GM

DEVELOPMENT OF IONIC CHANNELS

$222,517
University Of Houston · R01 · FY2001 · NS

Investigation of endocannabinoid-mediated neuroprotection in models of neuroAIDS

$222,486
Sylvia Fitting · Univ Of North Carolina Chapel Hill · R21 · FY2016 · DA

Nestorone and Estradiol-based Vaginal Ring for Contraception and Brain Health

$222,414
Regine L Sitruk-Ware · Population Council · U54 · FY2015 · HD

Molecular Analysis of the Ig Repertoire in MS

$222,300
University Of Texas Sw Med Ctr/Dallas · R01 · FY2003 · NS

Dual responsive nanoparticle for brain targeted drug delivery

$222,223
Peisheng Xu · University Of South Carolina At Columbia · P20 · FY2017 · GM

Corticotropin Releasing Factor: Impact on Inflammation

$222,197
Eric M Smith · University Of Texas Med Br Galveston · R21 · FY2009 · AI

Corticotropin Releasing Factor: Impact on Inflammation

$222,197
Eric M Smith · University Of Texas Med Br Galveston · R21 · FY2008 · AI

Therapeutic efficacy of metformin in the disease process of EAE

$222,117
Shailendra Giri · Mayo Clinic Rochester · R21 · FY2011 · NS

Regulation of gray matter myelination by adolescent binge ethanol treatment

$222,094
Chen Gu · Ohio State University · R21 · FY2017 · AA

Immulogical Niches and Non-invasive Biosensors for Autoimmune Monitoring

$222,002
Aaron Harvey Morris · University Of Michigan At Ann Arbor · R00 · FY2023 · EB

The Neuroimmunology Training Program at the University of Utah

$221,952
Ryan M O'Connell · University Of Utah · T32 · FY2022 · NS

Control of the Survival Pathways in TH17 Cells

$221,888
Xuexian Yang · University Of New Mexico Health Scis Ctr · R21 · FY2025 · AI

G-quadruplex Structures as Targets and Tools in ALS

$221,875
Pavel Ivanov · Brigham And Women'S Hospital · R21 · FY2016 · NS

Role of LAP positive immune cells in glioblastoma pathogenesis

$221,823
Howard L Weiner · Brigham And Women'S Hospital · R21 · FY2015 · NS

Regulation of T cell metabolism by DRAK2

$221,737
Craig M Walsh · University Of California-Irvine · R21 · FY2019 · AI

Technology Research and Development Project 1 (Guiding Beneficial Plasticity)

$221,623
Jonathan Rickel Wolpaw · Albany Research Institute, Inc. · P41 · FY2022 · EB

Allelic Expression Imbalance in Tuberous Sclerosis Complex

$221,598
Vinodh Narayanan · St. Joseph'S Hospital And Medical Center · R21 · FY2008 · NS

MRI Paramagnetic Rim Lesions as Biomarkers and Agents of Neurodegeneration in Multiple Sclerosis

$221,553
Christopher C. Hemond · Univ Of Massachusetts Med Sch Worcester · K23 · FY2025 · NS